O'Shaughnessy Asset Management’s iRadimed IRMD Stock Holding History

O'Shaughnessy Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52	Closed	-$2K	–	1842
2021 Q3	$2K	Buy	+52	New	+$1.77K	﹤0.01%	2481
2019 Q3	–	Sell	-4,673	Closed	-$96K	–	1108
2019 Q2	$96K	Sell	4,673 -2,233	-32%	-$52.6K	﹤0.01%	654
2019 Q1	$194K	Sell	6,906 -6,785	-50%	-$178K	﹤0.01%	546
2018 Q4	$335K	Sell	13,691 -1,512	-10%	-$40.6K	0.01%	400
2018 Q3	$565K	Buy	15,203 +3,796	+33%	+$102K	0.01%	351
2018 Q2	$237K	Sell	11,407 -7	-0.1%	-$124	0.01%	504
2018 Q1	$162K	Buy	+11,414	New	+$163K	﹤0.01%	553

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

RCG

Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

O'Shaughnessy Asset Management's IRMD Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of iRadimed (IRMD) in Q4 2021, closing a stake of 52 shares — an estimated $2K sold.

O'Shaughnessy Asset Management first reported a position in IRMD in Q1 2018 and held it in 7 quarters. The position peaked at $565K in Q3 2018. 96 funds tracked by Wall St. Rank hold IRMD as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining iRadimed position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 52 iRadimed shares in Q4 2021, an estimated $2K.
O'Shaughnessy Asset Management first reported a position in iRadimed in Q1 2018 and held it in 7 quarters.
O'Shaughnessy Asset Management's iRadimed position peaked at $565K in Q3 2018.
96 funds tracked by Wall St. Rank held iRadimed as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.